- Home
- FGEN vs NMTC Comparison
FGEN vs NMTC Comparison
Compare FGEN & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FGEN | NMTC |
|---|---|---|
| Founded | 1993 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.6M | 31.5M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | FGEN | NMTC |
|---|---|---|
| Price | $8.55 | $0.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $146.50 | $2.23 |
| AVG Volume (30 Days) | 39.5K | ★ 282.8K |
| Earning Date | 11-10-2025 | 12-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 53.38 | N/A |
| Revenue | $8,298,000.00 | ★ $12,097,692.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $31.19 |
| P/E Ratio | $0.17 | ★ N/A |
| Revenue Growth | N/A | ★ 250.35 |
| 52 Week Low | $4.85 | $0.40 |
| 52 Week High | $21.94 | $1.39 |
Technical Indicators
Market Signals| Indicator | FGEN | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 48.67 | 51.67 |
| Support Level | $8.30 | $0.69 |
| Resistance Level | $10.47 | $0.82 |
| Average True Range (ATR) | 0.61 | 0.07 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 22.58 | 62.74 |
Price Performance
Historical ComparisonAbout FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.